http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 28 Aug 2026 06:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Avricore+Grants+Options/26992749.html <p align="justify">VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,300,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.06 per common share.</p> <p align="justify">All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange.</p> <p align="justify">The options shall vest quarterly commencing on http://www.streetinsider.com/Press+Releases/Avricore+Grants+Options/26992749.html Fri, 28 Aug 2026 06:30:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 http://www.streetinsider.com/Press+Releases/Avricore+Grants+Options/26992749.html <p align="justify">VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,300,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.06 per common share.</p> <p align="justify">All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange.</p> <p align="justify">The options shall vest quarterly commencing on http://www.streetinsider.com/Press+Releases/Avricore+Grants+Options/26992749.html Fri, 28 Aug 2026 06:30:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 http://www.streetinsider.com/Press+Releases/Avricore+Grants+Options/26992749.html <p align="justify">VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,300,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.06 per common share.</p> <p align="justify">All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange.</p> <p align="justify">The options shall vest quarterly commencing on http://www.streetinsider.com/Press+Releases/Avricore+Grants+Options/26992749.html Fri, 28 Aug 2026 06:30:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 http://www.streetinsider.com/Press+Releases/Avricore+Grants+Options/26992749.html <p align="justify">VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,300,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.06 per common share.</p> <p align="justify">All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange.</p> <p align="justify">The options shall vest quarterly commencing on http://www.streetinsider.com/Press+Releases/Avricore+Grants+Options/26992749.html Fri, 28 Aug 2026 06:30:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 http://www.streetinsider.com/Press+Releases/Avricore+Grants+Options/26992749.html <p align="justify">VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,300,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.06 per common share.</p> <p align="justify">All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange.</p> <p align="justify">The options shall vest quarterly commencing on http://www.streetinsider.com/Press+Releases/Avricore+Grants+Options/26992749.html Fri, 28 Aug 2026 06:30:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 http://www.streetinsider.com/Globe+Newswire/Avricore+Grants+Options/26992749.html <p align="justify">VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,300,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.06 per common share.</p> <p align="justify">All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange.</p> <p align="justify">The options shall vest quarterly commencing on http://www.streetinsider.com/Globe+Newswire/Avricore+Grants+Options/26992749.html Fri, 28 Aug 2026 06:30:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 http://www.streetinsider.com/Globe+Newswire/Avricore+Grants+Options/26992749.html <p align="justify">VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,300,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.06 per common share.</p> <p align="justify">All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange.</p> <p align="justify">The options shall vest quarterly commencing on http://www.streetinsider.com/Globe+Newswire/Avricore+Grants+Options/26992749.html Fri, 28 Aug 2026 06:30:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 http://www.streetinsider.com/Globe+Newswire/Avricore+Grants+Options/26992749.html <p align="justify">VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,300,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.06 per common share.</p> <p align="justify">All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange.</p> <p align="justify">The options shall vest quarterly commencing on http://www.streetinsider.com/Globe+Newswire/Avricore+Grants+Options/26992749.html Fri, 28 Aug 2026 06:30:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 http://www.streetinsider.com/Globe+Newswire/Avricore+Grants+Options/26992749.html <p align="justify">VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,300,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.06 per common share.</p> <p align="justify">All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange.</p> <p align="justify">The options shall vest quarterly commencing on http://www.streetinsider.com/Globe+Newswire/Avricore+Grants+Options/26992749.html Fri, 28 Aug 2026 06:30:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 http://www.streetinsider.com/Globe+Newswire/Avricore+Grants+Options/26992749.html <p align="justify">VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,300,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.06 per common share.</p> <p align="justify">All Options were granted pursuant to the Company’s stock option plan and are subject to the terms of the applicable grant agreements and the requirements of the TSX Venture Exchange.</p> <p align="justify">The options shall vest quarterly commencing on http://www.streetinsider.com/Globe+Newswire/Avricore+Grants+Options/26992749.html Fri, 28 Aug 2026 06:30:00 -0400 A.36078215 AVCR AVCRF O.02555813 O.71644544 http://www.streetinsider.com/Press+Releases/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html <p>VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott, a global healthcare company, to supply and distribute Abbott’s point-of-care testing products through the HealthTab™ platform in the UK.</p> <p>The agreement allows HealthTab to distribute Abbott’s Afinion™ 2 Analyzer in NHS-linked pharmacies to test for HbA1c and lipid profiles. The collaboration also establishes a structured framework for the continued expansion of point-of-care testing through community pharmacies. “This agreement represents our most significant milestone to date,” http://www.streetinsider.com/Press+Releases/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html Thu, 20 Aug 2026 06:30:00 -0400 A.03186153 AVCR AVCRF O.50921235 O.71644544 http://www.streetinsider.com/Press+Releases/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html <p>VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott, a global healthcare company, to supply and distribute Abbott’s point-of-care testing products through the HealthTab™ platform in the UK.</p> <p>The agreement allows HealthTab to distribute Abbott’s Afinion™ 2 Analyzer in NHS-linked pharmacies to test for HbA1c and lipid profiles. The collaboration also establishes a structured framework for the continued expansion of point-of-care testing through community pharmacies. “This agreement represents our most significant milestone to date,” http://www.streetinsider.com/Press+Releases/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html Thu, 20 Aug 2026 06:30:00 -0400 A.03186153 AVCR AVCRF O.50921235 O.71644544 http://www.streetinsider.com/Press+Releases/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html <p>VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott, a global healthcare company, to supply and distribute Abbott’s point-of-care testing products through the HealthTab™ platform in the UK.</p> <p>The agreement allows HealthTab to distribute Abbott’s Afinion™ 2 Analyzer in NHS-linked pharmacies to test for HbA1c and lipid profiles. The collaboration also establishes a structured framework for the continued expansion of point-of-care testing through community pharmacies. “This agreement represents our most significant milestone to date,” http://www.streetinsider.com/Press+Releases/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html Thu, 20 Aug 2026 06:30:00 -0400 A.03186153 AVCR AVCRF O.50921235 O.71644544 http://www.streetinsider.com/Press+Releases/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html <p>VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott, a global healthcare company, to supply and distribute Abbott’s point-of-care testing products through the HealthTab™ platform in the UK.</p> <p>The agreement allows HealthTab to distribute Abbott’s Afinion™ 2 Analyzer in NHS-linked pharmacies to test for HbA1c and lipid profiles. The collaboration also establishes a structured framework for the continued expansion of point-of-care testing through community pharmacies. “This agreement represents our most significant milestone to date,” http://www.streetinsider.com/Press+Releases/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html Thu, 20 Aug 2026 06:30:00 -0400 A.03186153 AVCR AVCRF O.50921235 O.71644544 http://www.streetinsider.com/Press+Releases/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html <p>VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott, a global healthcare company, to supply and distribute Abbott’s point-of-care testing products through the HealthTab™ platform in the UK.</p> <p>The agreement allows HealthTab to distribute Abbott’s Afinion™ 2 Analyzer in NHS-linked pharmacies to test for HbA1c and lipid profiles. The collaboration also establishes a structured framework for the continued expansion of point-of-care testing through community pharmacies. “This agreement represents our most significant milestone to date,” http://www.streetinsider.com/Press+Releases/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html Thu, 20 Aug 2026 06:30:00 -0400 A.03186153 AVCR AVCRF O.50921235 O.71644544 http://www.streetinsider.com/Globe+Newswire/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html <p>VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott, a global healthcare company, to supply and distribute Abbott’s point-of-care testing products through the HealthTab™ platform in the UK.</p> <p>The agreement allows HealthTab to distribute Abbott’s Afinion™ 2 Analyzer in NHS-linked pharmacies to test for HbA1c and lipid profiles. The collaboration also establishes a structured framework for the continued expansion of point-of-care testing through community pharmacies. “This agreement represents our most significant milestone to date,” http://www.streetinsider.com/Globe+Newswire/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html Thu, 20 Aug 2026 06:30:00 -0400 A.03186153 AVCR AVCRF O.50921235 O.71644544 http://www.streetinsider.com/Globe+Newswire/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html <p>VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott, a global healthcare company, to supply and distribute Abbott’s point-of-care testing products through the HealthTab™ platform in the UK.</p> <p>The agreement allows HealthTab to distribute Abbott’s Afinion™ 2 Analyzer in NHS-linked pharmacies to test for HbA1c and lipid profiles. The collaboration also establishes a structured framework for the continued expansion of point-of-care testing through community pharmacies. “This agreement represents our most significant milestone to date,” http://www.streetinsider.com/Globe+Newswire/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html Thu, 20 Aug 2026 06:30:00 -0400 A.03186153 AVCR AVCRF O.50921235 O.71644544 http://www.streetinsider.com/Globe+Newswire/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html <p>VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott, a global healthcare company, to supply and distribute Abbott’s point-of-care testing products through the HealthTab™ platform in the UK.</p> <p>The agreement allows HealthTab to distribute Abbott’s Afinion™ 2 Analyzer in NHS-linked pharmacies to test for HbA1c and lipid profiles. The collaboration also establishes a structured framework for the continued expansion of point-of-care testing through community pharmacies. “This agreement represents our most significant milestone to date,” http://www.streetinsider.com/Globe+Newswire/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html Thu, 20 Aug 2026 06:30:00 -0400 A.03186153 AVCR AVCRF O.50921235 O.71644544 http://www.streetinsider.com/Globe+Newswire/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html <p>VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott, a global healthcare company, to supply and distribute Abbott’s point-of-care testing products through the HealthTab™ platform in the UK.</p> <p>The agreement allows HealthTab to distribute Abbott’s Afinion™ 2 Analyzer in NHS-linked pharmacies to test for HbA1c and lipid profiles. The collaboration also establishes a structured framework for the continued expansion of point-of-care testing through community pharmacies. “This agreement represents our most significant milestone to date,” http://www.streetinsider.com/Globe+Newswire/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html Thu, 20 Aug 2026 06:30:00 -0400 A.03186153 AVCR AVCRF O.50921235 O.71644544 http://www.streetinsider.com/Globe+Newswire/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html <p>VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott, a global healthcare company, to supply and distribute Abbott’s point-of-care testing products through the HealthTab™ platform in the UK.</p> <p>The agreement allows HealthTab to distribute Abbott’s Afinion™ 2 Analyzer in NHS-linked pharmacies to test for HbA1c and lipid profiles. The collaboration also establishes a structured framework for the continued expansion of point-of-care testing through community pharmacies. “This agreement represents our most significant milestone to date,” http://www.streetinsider.com/Globe+Newswire/HealthTab%E2%84%A2+Enters+Multi-Year+Collaboration+Agreement+with+Abbott+for+Point-of-Care+Testing+Across+the+UK/26952451.html Thu, 20 Aug 2026 06:30:00 -0400 A.03186153 AVCR AVCRF O.50921235 O.71644544 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Avricore+Health+Inc.++++++For%3A+Jun+30/26759156.html si-local-file:///var/storage/secattach/20260713/26759156.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Avricore+Health+Inc.++++++For%3A+Jun+30/26759156.html Mon, 13 Jul 2026 06:02:00 -0400 AVCR AVCRF O.71644544 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Avricore+Health+Inc.++++++For%3A+Jun+30/26759156.html si-local-file:///var/storage/secattach/20260713/26759156.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Avricore+Health+Inc.++++++For%3A+Jun+30/26759156.html Mon, 13 Jul 2026 06:02:00 -0400 AVCR AVCRF O.71644544 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Avricore+Health+Inc.++++++For%3A+Jun+30/26759156.html si-local-file:///var/storage/secattach/20260713/26759156.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Avricore+Health+Inc.++++++For%3A+Jun+30/26759156.html Mon, 13 Jul 2026 06:02:00 -0400 AVCR AVCRF O.71644544 http://www.streetinsider.com/Press+Releases/Avricore+Health+Closes+%241.254+Million+Financing/26656530.html <p align="justify">VANCOUVER, British Columbia, June 17, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the <strong>“Company”</strong> or <strong>“Avricore”</strong>) announces that, further to its news release dated May 20, 2026, the Company has closed its non-brokered private placement for gross proceeds of $1,254,000 by issuing 25,080,000 Units at $0.05 per Unit on June 16, 2026.</p> <p align="justify">Rodger Seccombe, CEO of Avricore stated, &quot;This financing provides the Company with the capital strength for its UK expansion. We appreciate the commitment from our investors as we prepare to execute on our growth strategy.&quot;</p> <p align="justify">Each Unit consists of http://www.streetinsider.com/Press+Releases/Avricore+Health+Closes+%241.254+Million+Financing/26656530.html Wed, 17 Jun 2026 06:30:00 -0400 A.35388043 A.36078215 AVCR AVCRF O.02555813 O.08414503 O.71644544 http://www.streetinsider.com/Press+Releases/Avricore+Health+Closes+%241.254+Million+Financing/26656530.html <p align="justify">VANCOUVER, British Columbia, June 17, 2026 (GLOBE NEWSWIRE) -- <strong>AVRICORE HEALTH INC.</strong> (TSXV: AVCR) (the <strong>“Company”</strong> or <strong>“Avricore”</strong>) announces that, further to its news release dated May 20, 2026, the Company has closed its non-brokered private placement for gross proceeds of $1,254,000 by issuing 25,080,000 Units at $0.05 per Unit on June 16, 2026.</p> <p align="justify">Rodger Seccombe, CEO of Avricore stated, &quot;This financing provides the Company with the capital strength for its UK expansion. We appreciate the commitment from our investors as we prepare to execute on our growth strategy.&quot;</p> <p align="justify">Each Unit consists of http://www.streetinsider.com/Press+Releases/Avricore+Health+Closes+%241.254+Million+Financing/26656530.html Wed, 17 Jun 2026 06:30:00 -0400 A.35388043 A.36078215 AVCR AVCRF O.02555813 O.08414503 O.71644544